Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Cognito Therapeutics CEO Brent Vaughan to Speak at CODE Conference 2021


Cognito Therapeutics, a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases, announced today its CEO Brent Vaughan will speak at CODE Conference, in Beverly Hills, CA, September 27-29, 2021 to discuss Cognito's ground-breaking technology that has shown the promise of slowing or stopping the progression of Alzheimer's and its potential to fundamentally expand human cognitive performance.

Event details:

Panel Session: Brain, body, soul - advancements in wellness technology

 

Date: Wednesday, September 29, 2021 (Morning Session)

 

Moderator: Kara Swisher, Executive Producer, Code Conference

 

Participants: Brent Vaughan, CEO, Cognito Therapeutics

Will Ahmed, Founder and CEO, Whoop

Casey Means M.D., Chief Medical Officer and Co-Founder, Levels

Code 2021 is an annual event hosted by Vox, created by Kara Swisher, that brings together the biggest names in tech. The invitation-only conference convenes the biggest names in the business ? executive leaders and promising entrepreneurs ? for networking and in-depth conversations. Confirmed speakers this year include Elon Musk, Kevin Durant, Marc Benioff, Ariel Emanuel, and Gary Gensler.

About Cognito Therapeutics

Cognito Therapeutics is a pioneer in non-invasive neuromodulation to treat neurodegenerative diseases and improve human cognitive performance. The company has completed multiple clinical studies demonstrating its investigational therapeutic has the potential to safely slow or stop cognitive decline and loss of brain volume in Alzheimer's disease. Cognito has received FDA Breakthrough Device Designation for the treatment of Alzheimer's disease and expects to start pivotal studies in 2022. The company's technology was based on pioneering optogenetics research by scientific co-founders Professors Li-Huei Tsai and Ed Boyden at MIT. Cognito Therapeutics is based in Cambridge, MA. For more information, please visit www.cognitotx.com. Follow us on Twitter at @cognitotx.


These press releases may also interest you

at 16:35
Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
Geron Corporation , a late-stage clinical biopharmaceutical company, today announced that it will release its first quarter 2024 financial results and business highlights before the market opens on Thursday, May 2, 2024 via press release, which will...

at 16:35
Tilray Brands Celebrates Big Wins at the Craft Brewer's Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World
Tilray Brands, Inc. , a leader in the craft beer and cannabis-lifestyle industries, celebrates high honors and awards at the 2024 Craft Brewer's Conference and World Beer Cup. 10 Barrel Brewing won four craft beer awards and 10...

at 16:34
Fusion Pharmaceuticals Mails Circular for Special Meeting of Shareholders and Announces Receipt of Interim Order
Fusion Pharmaceuticals Inc. , a clinical-stage oncology company focused on developing next-generation radioconjucates (RCs) as precision medicines, today announced that it has filed and is in the process of mailing the management information circular...

at 16:30
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
In an important step toward driving long-term affordability and access to treatments for chronic and complex conditions, Evernorth Health Services announced that it will have a Humira® biosimilar available for $0 out of pocket for eligible...

at 16:28
American Business Awards: Dr. Siva Mohan, CMO of RazorMetrics
Dr. Siva Mohan, Co-Founder and Chief Medical Officer of RazorMetrics, an Austin-based drug cost reduction platform, is the Best Entrepreneur - Health Products & Services Status: Silver Stevie Winner from the American Business Awards. The Stevie®...

at 16:20
Revvity Board Declares Quarterly Dividend
The Board of Directors of Revvity , today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on August 9, 2024 to all shareholders of record at the close of business on July 19, 2024. About Revvity ...

More news about Health...


News published on and distributed by: